Haemonetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.11.24	Haemonetics Q2 Results Top Estimates; Reaffirms FY25 Adj. EPS, Revenue Outlook (RTTNews)
08.08.24	Haemonetics Q1 Profit Slips, Despite Revenue Growth, Reaffirms FY25 Adj. EPS, Revenue Range (RTTNews)
23.05.24	Haemonetics Prices $600 Mln, 2.5% Convertible Sr. Notes (RTTNews)
09.05.24	Haemonetics Q4 Profit Falls, But Beats Estimates - Update (RTTNews)
04.04.24	Haemonetics Gets 510 (K) Clearance For TEG 6s Hemostasis - HN Cartridge (RTTNews)
05.03.24	Haemonetics To Acquire Attune Medical - Quick Facts (RTTNews)
08.02.24	Haemonetics Q3 Profit Down, But Beats Estimates; Lifts Annual Earnings Outlook Above View - Update (RTTNews)
12.12.23	Haemonetics Corporation Completes Acquisition of OpSens Inc. (PR Newswire)
07.12.23	Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
02.11.23	Haemonetics Q2 Adj. Profit Rises; Organic Revenue Up 7.6% (RTTNews)
02.11.23	Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
10.10.23	Haemonetics Agrees To Buy OpSens In $253 Mln All-cash Deal (RTTNews)
10.10.23	Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc. (PR Newswire)
05.10.23	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023 (PR Newswire)
29.08.23	Haemonetics Announces European Expansion for VASCADE® Vascular Closure System (PR Newswire)
08.08.23	Haemonetics Updates FY24 Adj. EPS Guidance (RTTNews)
08.08.23	Haemonetics 1st Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website (PR Newswire)
10.07.23	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2024 Results: August 8, 2023 (PR Newswire)
22.06.23	Haemonetics Announces FDA Clearance For Advancements To NexSys PCS Plasma Collection System (RTTNews)
22.06.23	Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System (PR Newswire)
11.05.23	Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website (PR Newswire)
25.04.23	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2023 Results: May 11, 2023 (PR Newswire)
27.02.23	Haemonetics to Present at Raymond James 44th Annual Institutional Investors Conference (PR Newswire)
07.02.23	Haemonetics 3rd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website (PR Newswire)
06.01.23	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2023 Results: February 7, 2023 (PR Newswire)
19.12.22	Haemonetics to Present at 41st Annual J.P. Morgan Healthcare Conference (PR Newswire)
07.11.22	Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website (PR Newswire)
06.10.22	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022 (PR Newswire)
24.08.22	Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference (PR Newswire)
10.08.22	Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website (PR Newswire)
07.07.22	Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2023 Results: August 10, 2022 (PR Newswire)
06.06.22	Haemonetics Corporation Announces Additional Information Regarding Its Investor Day on June 29, 2022 (PR Newswire)
10.05.22	Haemonetics Corp. Swings To Profit In Q4 (RTTNews)
10.05.22	Haemonetics to Host Investor Day Event on June 29, 2022 (PR Newswire)
10.05.22	Haemonetics 4th Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website (PR Newswire)
06.04.22	Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2022 Results: May 10, 2022 (PR Newswire)
23.02.22	Haemonetics to Present at Raymond James 43rd Annual Institutional Investors Conference (PR Newswire)
08.02.22	Haemonetics Q3 Profit Beats Estimates, Organic Revenue Down 0.8%; Updates FY22 Guidance (RTTNews)
08.02.22	Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website (PR Newswire)
05.01.22	Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022 (PR Newswire)
09.11.21	Haemonetics CFO To Retire In June Next Year (RTTNews)
09.11.21	Haemonetics Q2 Profit Down, Below Estimates (RTTNews)
09.11.21	Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website (PR Newswire)
09.11.21	Haemonetics Announces CFO William P. Burke's Retirement for June 2022 (PR Newswire)
06.10.21	Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021 (PR Newswire)
25.08.21	Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference (PR Newswire)
11.08.21	Haemonetics Slips To Q1 Loss, Adj. Earnings Top View; Backs FY22 Outlook (RTTNews)
11.08.21	Haemonetics 1st Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website (PR Newswire)
09.08.21	Lloyd E. Johnson Joins Haemonetics' Board of Directors; Ellen Zane Announced as New Board Chair (PR Newswire)
09.07.21	/C O R R E C T I O N -- Haemonetics Corporation/ (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Haemonetics Corp.

Aktien Top/Flop

Meistgelesene Nachrichten